Compare AVT & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVT | BCPC |
|---|---|---|
| Founded | 1921 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.6B |
| IPO Year | N/A | N/A |
| Metric | AVT | BCPC |
|---|---|---|
| Price | $65.39 | $180.38 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $54.33 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 1.7M | 164.1K |
| Earning Date | 01-28-2026 | 02-20-2026 |
| Dividend Yield | ★ 2.12% | 0.54% |
| EPS Growth | N/A | ★ 22.48 |
| EPS | 2.45 | ★ 4.57 |
| Revenue | ★ $23,150,745,000.00 | $1,013,548,000.00 |
| Revenue This Year | $14.21 | $10.41 |
| Revenue Next Year | $5.08 | $6.36 |
| P/E Ratio | ★ $26.96 | $38.81 |
| Revenue Growth | 2.96 | ★ 7.55 |
| 52 Week Low | $39.22 | $139.17 |
| 52 Week High | $67.57 | $182.42 |
| Indicator | AVT | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 78.06 | 71.54 |
| Support Level | $60.59 | $169.73 |
| Resistance Level | $67.57 | $182.42 |
| Average True Range (ATR) | 2.42 | 3.72 |
| MACD | 0.33 | 0.43 |
| Stochastic Oscillator | 88.03 | 77.69 |
Avnet Inc is an electronic component technology distributor and solutions provider. It serves customers from startups and mid-sized businesses to enterprise-level original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and original design manufacturers (ODMs). The group operates in the Electronic Components segment and supports high and medium-volume customers to markets, sells, and distributes electronic components, and the Farnell segment supports lower-volume customers that need electronic components quickly to develop, prototype, and test their products. Its geographic regions are the Americas, EMEA, and Asia.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.